Identifying molecular targets for diabetes-related ED
erectile dysfunction is one of the most prevalent diabetes-induced complications in men; current estimates suggest that as many as 75% of men with diabetes will develop some degree of ED, and in many cases diabetics develop more severe forms of ED that are less responsive to standard drugs.
Now, in a study appearing in the March Molecular and Cellular Proteomics , researchers at Case Western Reserve University and Albert Einstein College of Medicine have identified some of the molecular changes that accompany the onset of diabetes-induced ED, which may lead to markers that will help identify ED risk as well as new potential drug targets.
Mark Chance and colleagues used a proteomics approach to examine the relative abundance of proteins in the corpora (the expandable tissues along the length of the penis which fill with blood during erection) of diabetic rats at two different stages of progression: one week and two months after the onset of diabetes. By comparing these rats to healthy age-matched controls, they identified 57 proteins in the penile tissue that either increased or decreased during diabetes.
The candidate proteins revealed insights into the mechanics of ED; perhaps not surprisingly, collagen proteins that provide strength and stiffness were down-regulated in diabetes, as were proteins that transport sex hormones. Meanwhile, proteins involved in cell death (apoptosis) were up-regulated, as were many proteins related to fat metabolism, changes that might be related to narrowing or hardening of blood vessels.
Chance and colleagues note that the rat model they used in the study mimics many relevant features of human ED, and thus the identification of these 57 candidate proteins could open up further and more detailed studies into the relationship between diabetes and ED in humans, and also lead to diagnostic and drug targets.
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
Genetically engineered crops benefit many farmers, but the technology needs proper management to remain effective
Pramocaine
Genzyme Phase 3 Trial of Campath/Fludara Combination Shows Potential Benefit in Second-Line CLL
Dietary fibre powers the multivitamin factory in your gut - Luxembourg Institute of Health reveals critical link between fibre intake, gut bacteria, B vitamins and immune health
Tarceva helps patients with genetically distinct form of lung cancer live longer - Phase II study points to importance of EGFR biomarker to identify patients who can gain exceptional survival benefits
TSUBAME supercomputer predicts cell-membrane permeability of cyclic peptides
Mechanism of dengue virus entry into cells
Gene that improves quality of reprogrammed stem cells identified by Singapore scientists - Provides 'a better inkling of what we might aim for before differentiating iPS cells to clinically useful cell types'
One synthetic molecule, two doorways into cell
Vasa_praevia
Chemists create eco-friendly method to make chlorine-based materials for drugs and chemicals - “Our method uses sustainable, low-cost catalysts and operates at room temperature with gentle blue light”
